Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 1-10 of 43

Page
per page
  1. PFI-2
    B4875 PFI-2
     1 Citation
    Target: SETD7
    Summary: SETD7 methyltransferase inhibitor
      ≥50 mg/mL
  2. Apicidin
    A8176 Apicidin
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      soluble in DMSO or ethanol
  3. I-BET-762
    B1498 I-BET-762
     4 Citation
    Target: Bromodomains
    Summary: BET inhibitor,highly potent
      ≥21.19 mg/mL
  4. Entinostat (MS-275,SNDX-275)
    A8171 Entinostat (MS-275,SNDX-275)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1 and HDAC3 inhibitor
      insoluble in H2O; ≥18.8 mg/mL
  5. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL
  6. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  7. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  8. TCS 401
    A4545 TCS 401
    Summary: Selective PTP1B inhibitor
      Soluble in DMSO
  9. Nexturastat A
    B3704 Nexturastat A
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,highly potent and selective
      insoluble in H2O; ≥16.3 mg/mL
  10. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL

Items 1-10 of 43

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 3item
  2. Aurora Kinase 6item
  3. DNA Methyltransferase 2item
  4. HDAC 11item
  5. Histone Acetyltransferases 1 item
  6. Histone Demethylases 1 item
  7. Histone Methyltransferase 7item
  8. JAK 7item
  9. PARP 2item
  10. Pim 1 item
  11. Protein Ser/Thr Phosphatases 2item
  12. Sphingosine Kinase-2 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 10item
  3. PI3K 1 item
  4. Aurora Kinases 6item
  5. EZH2 2item
  6. Bromodomains 2item
  7. FLT3 1 item
  8. MEK 1 item
  9. DOT1L 1 item
  10. Pim 1 item
  11. Src 1 item
  12. STAT 1 item
  13. JAK 7item
  14. EZH1 1 item
  15. TNKS 1 item
  16. DNA Methyltransferases 2item
  17. SMYD2 1 item
  18. PARP 1 item
  19. phosphatases 1 item
  20. G9a 1 item
  21. SETD7 1 item
  22. Cytidine deaminases 1 item
  23. c-RET 1 item
  24. Histone Acetyltransferases (HATs) 1 item
  25. Lck 1 item
  26. SK 1 item
Reported Experiments
  1. Animal Experiments 32item
  2. Cell Experiments 24item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Bladder Carcinoma 1 item
  3. Breast Cancer 9item
  4. Cancer 24item
  5. Castration-resistant Prostate Cancer 1 item
  6. Cervical Cancer 1 item
  7. Colon Cancer 4item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 1 item
  10. Diabetes 1 item
  11. Diffuse Large B-cell Lymphoma 1 item
  12. Glioblastoma 1 item
  13. Glioma 2item
  14. Hepatocellular Carcinoma 1 item
  15. HIV Infections 1 item
  16. Immunological Diseases 1 item
  17. Inflammatory Bowel Disease 1 item
  18. Inflammatory Diseases 1 item
  19. Leukemia 3item
  20. Lung Cancer 3item
  21. Lymphoma 1 item
  22. Melanoma 1 item
  23. Mixed Lineage Leukemia 1 item
  24. Multiple Myeloma 3item
  25. Myelofibrosis 1 item
  26. Myeloma 1 item
  27. Non-small Cell Lung Cancer 3item
  28. Ovarian Cancer 1 item
  29. Pancreatic Cancer 2item
  30. Prostate Cancer 6item
  31. Psoriasis 1 item
  32. Renal Cell Carcinoma 1 item
  33. Rheumatoid Arthritis 3item